在Impella CP支持下,救助皮肤穿透冠状动脉干预iatrogenic左主冠状动脉剖析:一个案例报告
Yuki Nakata1, Takayuki Okamura1, Masaki Tamitani1
1Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, 1-1-1, Minami-kogushi, Ube 755-8505, Japan.
European heart journal. Case reports
|January 12, 2026
概括
早期的Impella CP支持稳定了血液动力学,并在救助期间保留了真光,用于iatrogenic左主冠状动脉剖析的穿皮冠状动脉干预,使得支架成功.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 一位55岁的妇女出现了反复出现的胸部紧张.
- 冠状动脉计算机断层扫描显示没有显著的狭窄.
研究的目的:
- 在乙胆挑测试期间报告一种阳性性左主冠状动脉解剖病例.
- 要突出Impella CP支持在管理这种并发症中的作用.
主要方法:
- 乙胆挑测试导致左主冠状动脉解剖和心脏性休克.
- 插入Impella CP装置用于血液动力学稳定.
- 血管内超声波对光膜完整性的评估.
- 救助皮肤冠状动脉干预与支架部署和吻气球膨胀.
主要成果:
- 支持Impella CP迅速稳定了血液动力学和改善了ST段抑郁.
- 血管内超声波显示了虚假光线的动态减少和真光线的扩张.
- 在经皮冠状动脉干预后成功恢复TIMI 3级流动.
结论:
- 早期的Impella CP支持对于iatrogenic左主冠状动脉剖析中的血液动力稳定至关重要.
- 支持Impella促进了成功的救助通过皮肤冠状动脉干预.
- 血管内超声波为Impella支持的疗效提供了宝贵的见解.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326


